<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-vaccines-08-00307">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beltramello</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Simmons</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Macagno</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Simonelli</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Quyen</surname>
    <given-names>N.T.</given-names>
   </name>
   <name>
    <surname>Sukupolvi-Petty</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Navarro-Sanchez</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>P.R.</given-names>
   </name>
   <name>
    <surname>de Silva</surname>
    <given-names>A.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity</article-title>
  <source>Cell Host Microbe</source>
  <year>2010</year>
  <volume>8</volume>
  <fpage>271</fpage>
  <lpage>283</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chom.2010.08.007</pub-id>
  <pub-id pub-id-type="pmid">20833378</pub-id>
 </element-citation>
</ref>
